Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
China Vaccine Industry Report, 2009-2010
US$ 1,900.00
Price:Hard Copy: US$ 1,900.00 PDF for Single User: US$ 2,000.00 PDF for Enterprisewide: US$ 3,000.00Being one of the world's largest vaccine producers, China not only has many vaccine companies, vari...
September 2010
111 pages
Competitor Analysis: Streptococcal Vaccines and Antibodies
US$ 230.00
... A Streptococcus Group B Streptococcus Other Streptococcal Vaccine & Antibody R&D Agreements Corporate Streptococcal Vaccines & Antibody R&D Pipelines About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D ...
June 2010
18 pages
Competitor Analysis: P. aeruginosa Vaccines and Therapeutics
US$ 230.00
... P. aeruginosa Peptides P. Aeruginosa Small Molecules P. aeruginosa R&D Licensing Agreements Corporate P. aeruginosa Vaccines & Therapeutics R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of ...
June 2010
22 pages
Competitor Analysis: HPV Vaccines
US$ 172.50
... of the three recommended doses when they were younger. The approved vaccines protect against two or four, respectively, most common types ... a hyperlink leading to the source of information. Index HPV Vaccines Corporate HPV Vaccines R&D Pipelines About La Merie About Competitor Analysis Series The ...
May 2010
18 pages
Research Report Chinese Bird Flu Vaccine Industry, 2009
US$ 1,414.50
Zoonosis refers to a kind of infectious disease that plagues between animals and human beings. Some plagues, though discovered, spread widely all over the world. Others are newly found, such as the sw...
April 2009
60 pages
Research Report on China's Animal Vaccine Industry, 2009
US$ 1,552.50
In 2008, the market size of Chinese animal vaccine is about 3 billion Yuan (0.43 billion US Dollars), increased by 30% in 2007, and will still keep a fast growth in years. This depends on many factors...
March 2009
60 pages
Research Report on China Avian Influenza Vaccine Industry, 2014-2018
US$ 1,800.00
... avian influenza vaccines voluntarily 10 years ago without compulsory requirements. Chinese avian influenza vaccine industry was in the initial stage in 2001-2005 ... Influenza Vaccines and the Operation Status in China Prospect of China Avian Influenza Vaccine Industry The Following Enterprises and People Are ...
June 2026
-
Research Report on China Swine Fever Vaccine Industry, 2014-2018
US$ 1,800.00
... while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. Swine fever is considered a highly infectious disease that needs strict prevention, ... Swine Fever Vaccines and the Operation Status in China Prospect of China Swine Fever Vaccine Industry The Following Enterprises and People Are ...
June 2026
-
Global In Ovo Vaccination Equipment Market Growth 2026-2032
US$ 3,660.00
The global In Ovo Vaccination Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market f...
June 2026
84 pages
